Literature DB >> 23706110

Synthesis and comparison of transition metal complexes of abnormal and normal tetrazolylidenes: a neglected ligand species.

Lars-Arne Schaper1, Xuhui Wei, Philipp J Altmann, Karl Öfele, Alexander Pöthig, Markus Drees, János Mink, Eberhardt Herdtweck, Bettina Bechlars, Wolfgang A Herrmann, Fritz E Kühn.   

Abstract

To date, only few examples of tetrazolylidene carbenes coordinated to transition metal complexes have been described. A direct comparison of "normal" tetrazolylidenes (1,4-substitution pattern) and "abnormal" tetrazolylidenes (also referred to as "mesoionic carbenes"; 1,3-substitution pattern) has not been performed at all. In this work, we describe coordination of both ligand types to a row of transition metals. For example, the first examples of tetrazolylidene Mo, Ag, or Ir complexes have been isolated and fully characterized. The mesoionic tetrazolylidene Ag compound 2d is shown to be a viable carbene transfer reagent. By means of NMR, IR, and Raman spectroscopy, as well as X-ray crystallography and computational results, the pronounced differences between the two ligand substitution patterns are highlighted. It is shown that simply changing the position of a methyl group from N3 to N4 in the heterocycle can cause enormous differences in ligand characteristics.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23706110     DOI: 10.1021/ic4005449

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  2 in total

1.  Theoretical descriptions of novel triplet germylenes M1-Ge-M2-M3 (M1 = H, Li, Na, K; M2 = Be, Mg, Ca; M3 = H, F, Cl, Br).

Authors:  Mohamad Zaman Kassaee; Samaneh Ashenagar
Journal:  J Mol Model       Date:  2018-02-06       Impact factor: 1.810

2.  Novel triplet germylenes in focus: normal vs. abnormal triplet exocyclic tetrazol-5-vinylidene germylenes at DFT.

Authors:  Samaneh Ashenagar; Mohamad Zaman Kassaee; Peter T Cummings
Journal:  J Mol Model       Date:  2019-12-02       Impact factor: 1.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.